Manmohan Singh cannot be kept out of CBI probe: Jaitley

October 18, 2013

JaitleyNew York, Oct 18: Prime Minister Manmohan Singh cannot be kept out of the CBI probe into the controversial coal block allocation as he was the "competent authority" when the decision was taken, senior BJP leader Arun Jaitley said today.

Naming industrialist Kumar Mangalam Birla and former coal secretary P C Parakh by the CBI in its FIR sent a "very, very adverse" signal that investors and civil servants will face investigation for irregularities, while the "competent authority" in the case, the Prime Minister who held the coal portfolio, "will go scot-free", Jaitley said.

He said successive corruption scandals like the spectrum and coal blocks allocation are adding to the "disillusionment" towards the UPA government.

"This (coal block allocation) case is going to send a very, very adverse signal to both international and domestic investors," Jaitley told PTI here.

The Leader of the Opposition in Rajya Sabha said it defied logic that a secretary to the government who recommends a coal block should be made an accused in an FIR filed by the CBI but the minister who sanctions the blocks should be out of it.

"The competent authority was the minister, the minister in this case happened to be the Prime Minister," he said. Jaitley said Parakh was only a "recommending authority" but has been named as an accused in the FIR. "The automatic corollary of this has to be that the minister in charge, who was the Prime Minister, cannot be kept out. He is the competent authority."

The FIR has named Parakh and Birla for criminal conspiracy and under provisions of the Prevention of Corruption Act in the allocation of two coal blocks in Odisha in 2005.Jaitley described Birla as "one of the doyens of the industry" and Parakh as an "an honest civil servant" who as a "dissenter" in the coal bloc allocation had recommended auction of coal.

"This case sends three signals. The investor is being told that if you invest in India, years later your projects and allocations can be reviewed by the investigating agencies and the head of your organisation will face criminal investigation.

"The politician is being told that the civil servant will be liable and the competent authority, who is the politician, will go scot free."

Jaitley added that the treatment meted out to Parakh is a warning to bureaucrats that "even the most honest civil servants will be investigated." The "net effect" will be that apart from foreign investments drying up, even domestic investors "will now be compelled to go outside." "This sends a very bad signal to investment. If honest civil servants are going to be squeezed to save the politicians, bureaucrats will stop making honest recommendations," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 10,2020

Bengaluru, Jun 10: Congress' Rajya Sabha candidate from Karnataka and senior leader Mallikarjun Kharge and his son received threat calls on Sunday, with the latter filing a complaint with the state police chief. Kharge, a former Union Minister, received the call in the wee hours of Sunday on his landline while his son Priyank later got a call from a private number on his mobile phone.

Priyank lodged a complaint with the Director-General of Police Praveen Sood and former MLC Ramesh Babu shared the copy of the complaint on Twitter on Tuesday. In his complaint, Priyank Kharge stated that at about 1.30 am on Sunday, his father received a call on the landline where the caller spoke in Hindi and English and used invective against the Congress veteran.

The caller, according to the complaint, spoke about the Rajya Sabha election and threatened Kharge. Police are looking into the matter. Kharge is the Congress' pick for the June 19 Rajya Sabha election from Karnataka. JD(S) supremo and former Prime Minister Deve Gowda and two BJP candidates have also filed nominations for the election to the upper House.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 7,2020

New Delhi, May 7: Prime Minister Narendra Modi on Thursday hailed people leading the fight against coronavirus and said India is standing firmly with those facing difficult times during the pandemic, both in the country and abroad.

He also said India's development will always aid global growth.

Speaking at a global virtual Buddha Purnima event, Modi said, "People world over working selflessly for others in these difficult times are worthy of praise."

"India is standing strong and selflessly in these difficult times with those facing trouble in India or abroad. India's growth will always be aiding global growth," he said.

Buddha Purnima celebrations are being held virtually due to the COVID-19 pandemic.

The event is being organised in the honour of COVID-19 victims and frontline warriors.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.